Eisai Co., Ltd.

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Eisai Co., Ltd.

Eisai Co., Ltd. (エーザイ株式会社, 4523), Pharmaceutical. 9 cross-shareholdings, a board of 11 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YB05, filed 2026-06-12. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-31756.248.01,239.3167.27160.0011,322
2023-03-31744.455.41,263.3193.31160.0011,076
2024-03-31741.842.41,393.8147.86160.0011,067
2025-03-31789.446.41,386.5163.76160.0010,917
2026-03-31825.438.61,449.1136.78160.0010,543

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
MatsukiyoCocokara&Co.4,545,00011.51.1
NIHON KOHDEN CORPORATION1,087,6001.60.7
INTAGE HOLDINGS Inc.598,5001.01.6
Cogstate Ltd.3,991,0030.9—
LIFENET INSURANCE COMPANY349,0000.70.4
HOKUYAKU TAKEYAMA Holdings,Inc.546,0050.52.7
PRISM BioLab Co.,LTD500,0000.11.4
SUZUKEN CO.,LTD.1000.00.0

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown